iRhythm Technologies, Inc. (NASDAQ:IRTC - Get Free Report)'s share price gapped up before the market opened on Monday . The stock had previously closed at $100.67, but opened at $103.89. iRhythm Technologies shares last traded at $100.40, with a volume of 10,786 shares changing hands.
Wall Street Analyst Weigh In
Several equities research analysts recently issued reports on IRTC shares. Canaccord Genuity Group raised their target price on shares of iRhythm Technologies from $125.00 to $152.00 and gave the stock a "buy" rating in a report on Monday, December 9th. Oppenheimer lifted their price objective on iRhythm Technologies from $105.00 to $120.00 and gave the stock an "outperform" rating in a report on Wednesday, January 8th. Wells Fargo & Company upped their price objective on iRhythm Technologies from $86.00 to $104.00 and gave the company an "equal weight" rating in a research report on Friday, February 21st. Truist Financial raised their target price on iRhythm Technologies from $111.00 to $145.00 and gave the stock a "buy" rating in a research report on Friday, February 21st. Finally, StockNews.com raised shares of iRhythm Technologies from a "sell" rating to a "hold" rating in a research report on Monday, February 24th. Three investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $119.73.
Check Out Our Latest Stock Analysis on IRTC
iRhythm Technologies Trading Up 0.1 %
The stock's 50-day simple moving average is $107.63 and its two-hundred day simple moving average is $88.39. The company has a debt-to-equity ratio of 9.00, a current ratio of 6.27 and a quick ratio of 6.12. The firm has a market capitalization of $3.28 billion, a P/E ratio of -28.71 and a beta of 1.36.
iRhythm Technologies (NASDAQ:IRTC - Get Free Report) last issued its quarterly earnings results on Thursday, February 20th. The company reported $0.01 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.29) by $0.30. The business had revenue of $164.33 million during the quarter, compared to analyst estimates of $158.30 million. iRhythm Technologies had a negative return on equity of 118.83% and a negative net margin of 19.14%. Equities research analysts expect that iRhythm Technologies, Inc. will post -1.98 EPS for the current year.
Institutional Inflows and Outflows
Large investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its position in shares of iRhythm Technologies by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 3,136,370 shares of the company's stock valued at $282,806,000 after buying an additional 18,442 shares during the last quarter. State Street Corp grew its stake in iRhythm Technologies by 1.3% during the third quarter. State Street Corp now owns 908,843 shares of the company's stock valued at $67,473,000 after acquiring an additional 11,992 shares in the last quarter. Braidwell LP increased its holdings in iRhythm Technologies by 48.7% in the 3rd quarter. Braidwell LP now owns 782,557 shares of the company's stock valued at $58,097,000 after acquiring an additional 256,200 shares during the last quarter. Eventide Asset Management LLC lifted its stake in iRhythm Technologies by 170.8% in the 3rd quarter. Eventide Asset Management LLC now owns 736,721 shares of the company's stock worth $54,694,000 after purchasing an additional 464,629 shares in the last quarter. Finally, Geode Capital Management LLC boosted its holdings in shares of iRhythm Technologies by 0.7% during the 3rd quarter. Geode Capital Management LLC now owns 733,308 shares of the company's stock valued at $54,451,000 after purchasing an additional 5,423 shares during the last quarter.
About iRhythm Technologies
(
Get Free Report)
iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.
See Also
Before you consider iRhythm Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and iRhythm Technologies wasn't on the list.
While iRhythm Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
